Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT03196427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis
Crohn's Disease

Interventions

DRUG: Vedolizumab

Sponsor

Takeda

Collaborators

[object Object]